Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma

Clinical and Experimental Medicine

Volumn 9, Issue 3, 2009, Pages 207-213

  Zhang, Hai Yan ^a   Meng, Xin ^a,b   Du, Zhen Xian ^a   Fang, Chang Qing ^a   Liu, Guo Liang ^a   Wang, Hua Qin ^a   Deng, Wei Wei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Apoptosis; Caspase 3; Survivin; Thyroid carcinoma; VEGF

Indexed keywords

CASPASE 3; MESSENGER RNA; SURVIVIN; VASCULOTROPIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; VASCULOTROPIN A;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID CARCINOMA; THYROID GLAND; ADULT; AGED; BIOSYNTHESIS; FEMALE; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID TUMOR;

ADULT; AGED; CASPASE 3; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 70349787131     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0031-7     Document Type: Article

References (27)

1. O'Neill P, Dornan T, Denning D (eds) (2003) Medicine: a core text with self-assessment, 2nd edn. Peking University Medical Press, Peking
2. H Kawasaki M Toyoda H Shinohara, et al. 2001 Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis Cancer 91 2026 2032 11391581 10.1002/1097- 0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E 1:CAS:528: DC%2BD3MXktlyjtbk%3D (Pubitemid 32476366)
3. MG Shu XT Guo HN Zhen, et al. 2007 Enhancing skin flap survival by a cell-permeable wild-type survivin Med Hypotheses 69 888 891 17376603 10.1016/j.mehy.2006.11.055 1:CAS:528:DC%2BD2sXpt1SgsLc%3D (Pubitemid 47260663)
4. K Tanaka S Iwamoto G Gon T Nohara M Iwamoto N Tanigawa 2000 Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 127 134 10656440 1:CAS:528:DC%2BD3cXhtVCjsr4%3D
5. J Kato Y Kuwabara M Mitani, et al. 2001 Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 95 92 95 11241318 10.1002/1097-0215(20010320)95:2<92::AID- IJC1016>3.0.CO;2-9 1:CAS:528:DC%2BD3MXitV2ks7w%3D (Pubitemid 32187079)
6. EJ Schlette LJ Medeiros A Goy R Lai GZ Rassidakis 2004 Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma J Clin Oncol 22 1682 1688 15117990 10.1200/JCO.2004.10.172 1:CAS:528: DC%2BD2cXpsVWlsrc%3D (Pubitemid 41079807)
7. S Shin BJ Sung YS Cho, et al. 2001 An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 Biochemistry 40 1117 1123 11170436 10.1021/bi001603q 1:CAS:528:DC%2BD3MXksl2k (Pubitemid 32108606)
8. A Ma R Lin PK Chan, et al. 2007 The role of survivin in angiogenesis during zebrafish embryonic development BMC Dev Biol 7 50 17511868 10.1186/1471-213X-7-50 (Pubitemid 46849100)
9. EA Beierle A Nagaram W Dai M Iyengar MK Chen 2005 VEGF-mediated survivin expression in neuroblastoma cells J Surg Res 127 21 28 15882878 10.1016/j.jss.2005.03.009 1:CAS:528:DC%2BD2MXlt1Knsb8%3D (Pubitemid 40814626)
10. K Kobayashi M Hatano M Otaki T Ogasawara T Tokuhisa 1999 Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation Proc Natl Acad Sci USA 96 1457 1462 9990045 10.1073/pnas.96.4.1457 1:CAS:528:DyaK1MXhsFSru74%3D (Pubitemid 29098472)
11. BT Takizawa EM Uchio JJ Cohen MA Wheeler RM Weiss 2007 Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells Cancer Invest 25 678 684 18058462 10.1080/07357900701600954 1:CAS:528: DC%2BD2sXhtl2isrjM (Pubitemid 350223166)
12. Z Ai L Yin X Zhou, et al. 2006 Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer Cancer 107 746 756 16826583 10.1002/cncr.22044 1:CAS:528:DC%2BD28XpsFGktLY%3D (Pubitemid 44232667)
13. MH Malcles HW Wang A Koumi, et al. 2007 Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death Br J Cancer 96 1659 1666 17505517 10.1038/sj.bjc.6603768 1:CAS:528: DC%2BD2sXlvVShsb8%3D (Pubitemid 46847194)
14. A Nassar D Lawson G Cotsonis C Cohen 2008 Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome Appl Immunohistochem Mol Morphol 16 113 120 18227733 10.1097/PAI.0b013e318032ea73 1:CAS:528:DC%2BD1cXktVWgsbk%3D
15. C Tanaka K Uzawa T Shibahara H Yokoe H Noma H Tanzawa 2003 Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis J Dent Res 82 607 611 12885844 10.1177/154405910308200807 1:CAS:528:DC%2BD3sXmslSntrY%3D
16. V Haghpanah P Shooshtarizadeh R Heshmat B Larijani SM Tavangar 2006 Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma Appl Immunohistochem Mol Morphol 14 422 425 17122639 10.1097/01.pai.0000213100.88074.b8 (Pubitemid 44813703)
17. Y Ito H Yoshida T Uruno, et al. 2003 Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma Oncol Rep 10 1337 1340 12883703
18. M Macluskey LM Chandrachud S Pazouki, et al. 2000 Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression J Pathol 191 368 375 10918211 10.1002/1096-9896(2000)9999:9999<:: AID-PATH652>3.0.CO;2-Y 1:STN:280:DC%2BD3cvivFKitg%3D%3D (Pubitemid 30649905)
19. PC Wu VK Lau JW Fang VC Lai CL Lai JY Lau 1999 Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma Liver 19 444 451 10533805 10.1111/j.1478-3231.1999.tb00076.x 1:STN:280: DC%2BD3c%2FgtFeksA%3D%3D (Pubitemid 29457225)
20. X Hao M Du AE Bishop IC Talbot 1998 Imbalance between proliferation and apoptosis in the development of colorectal carcinoma Virchows Arch 433 523 527 9870685 10.1007/s004280050284 1:STN:280:DyaK1M%2Fos1agsA%3D%3D (Pubitemid 28561184)
21. FA Sinicrope G Roddey TJ McDonnell Y Shen KR Cleary LC Stephens 1996 Increased apoptosis accompanies neoplastic development in the human colorectum Clin Cancer Res 2 1999 2006 9816159 1:CAS:528:DyaK2sXitlKqsw%3D%3D
22. F Farina F Cappello M Todaro, et al. 2000 Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease J Histochem Cytochem 48 57 62 10653586 1:CAS:528:DC%2BD3cXntFCqsw%3D%3D
23. T Tonini F Rossi PP Claudio 2003 Molecular basis of angiogenesis and cancer Oncogene 22 6549 6556 14528279 10.1038/sj.onc.1206816 1:CAS:528:DC%2BD3sXnsl2rs7o%3D
24. S Hoffmann A Wunderlich I Celik, et al. 2006 Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy J Cell Biochem 98 954 965 16475167 10.1002/jcb.20832 1:CAS:528: DC%2BD28XmsFyksbo%3D (Pubitemid 43993409)
25. JM Vieira SC Santos C Espadinha, et al. 2005 Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop Eur J Endocrinol 153 701 709 16260429 10.1530/eje.1.02009 1:CAS:528:DC%2BD2MXht1KgurjK (Pubitemid 41672417)
26. AB Kilicarslan M Ogus C Arici HE Pestereli M Cakir G Karpuzoglu 2003 Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas APMIS 111 439 443 12752224 10.1034/j.1600-0463.2003.t01-1- 1110209.x 1:CAS:528:DC%2BD3sXkt1KmsLY%3D (Pubitemid 36560544)
27. I Lewy-Trenda A Wierzchniewska-Lawska 2002 Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors Pol J Pathol 53 129 132 12476614 1:CAS:528:DC%2BD38XpsFKlsLo%3D